Similar articles for PMID: 20724533

Year	Number of Results
1993	1
2005	2
2006	5
2007	4
2008	5
2009	6
2010	7
2011	2
2012	1
2013	1
2014	2
2017	4
2019	1
2021	0

1

Whole-body 18F-FDG PET/CT: the need for a standardized field of view--a referring-physician aid.

Huston SF, Abdelmalik AG, Nguyen NC, Farghaly HR, Osman MM. Huston SF, et al. J Nucl Med Technol. 2010 Sep;38(3):123-7. doi: 10.2967/jnmt.109.073353. Epub 2010 Aug 19. J Nucl Med Technol. 2010. PMID: 20724533 Free article.

2

Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.

Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW Jr, Pinto H, Kaplan MJ. Quon A, et al. J Nucl Med. 2007 Jan;48 Suppl 1:58S-67S. J Nucl Med. 2007. PMID: 17204721 Free article. Review.

3

Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.

Metser U, Even-Sapir E. Metser U, et al. Semin Nucl Med. 2007 May;37(3):206-22. doi: 10.1053/j.semnuclmed.2007.01.001. Semin Nucl Med. 2007. PMID: 17418153

4

Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.

Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G. Pelosi E, et al. Q J Nucl Med Mol Imaging. 2006 Mar;50(1):15-22. Q J Nucl Med Mol Imaging. 2006. PMID: 16557200 Free article.

5

Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.

Beyer T, Bockisch A, Kühl H, Martinez MJ. Beyer T, et al. J Nucl Med. 2006 Jan;47(1):91-9. J Nucl Med. 2006. PMID: 16391192 Free article.

6

Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.

Graafland NM, Leijte JA, Valdés Olmos RA, Hoefnagel CA, Teertstra HJ, Horenblas S. Graafland NM, et al. Eur Urol. 2009 Aug;56(2):339-45. doi: 10.1016/j.eururo.2009.05.016. Epub 2009 May 19. Eur Urol. 2009. PMID: 19477581

7

PET/CT for the staging and follow-up of patients with malignancies.

Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. Poeppel TD, et al. Eur J Radiol. 2009 Jun;70(3):382-92. doi: 10.1016/j.ejrad.2009.03.051. Epub 2009 Apr 29. Eur J Radiol. 2009. PMID: 19406595 Review.

8

In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.

Wild D, Eyrich GK, Ciernik IF, Stoeckli SJ, Schuknecht B, Goerres GW. Wild D, et al. J Craniomaxillofac Surg. 2006 Jan;34(1):9-16. doi: 10.1016/j.jcms.2005.08.001. Epub 2005 Dec 15. J Craniomaxillofac Surg. 2006. PMID: 16343913

9

Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.

Brechtel K, Klein M, Vogel M, Mueller M, Aschoff P, Beyer T, Eschmann SM, Bares R, Claussen CD, Pfannenberg AC. Brechtel K, et al. J Nucl Med. 2006 Mar;47(3):470-6. J Nucl Med. 2006. PMID: 16513616 Free article. Clinical Trial.

10

Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.

Israel O, Kuten A. Israel O, et al. J Nucl Med. 2007 Jan;48 Suppl 1:28S-35S. J Nucl Med. 2007. PMID: 17204718 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed